. >> it was stolen from a drive in walnut creek, kirk johnson, who just retired from c.h.p. >> we have had the car throughout the family, my younger son had knit los angeles, and we recovered it and we were going to donate it. >> the suspect suffered minor injuries and faces multiple charges. he was spotted driving the stolen car solo in a car pool lane. >>> a man driving a stolen u-haul made this big mess in oakland after 5:00 this morning and that pickup smashed into three cars at 4th avenue and 30th across the street from highland hospital. it sheared a out -- utility pole. >> vehicle was going 90 miles per hour. too fast, and overcorrected and struck the sidewalk, hits the three cars. he wanted to get away and someone helped him down but his legs were like noodles and he had to sit on that chair and they took him to the hospital. >> we don't have any word on his condition. police say they smelled alcohol on his breath when they arrived at the seen. >>> bart has launch an investigation in the weighing of a new video circulating online. police officers using taser on a man in front o

. >> kirk johnson worked for the u.s. agency for international development in fallujah, iraq. when his iraqi colleagues started getting asass natured he started an organization to help them plea to the u.s. >> these are the good guys. and they're being hunted by the bad guys and we need to protect the good guys. so five years ago, six years ago we had this debate as a nation and we said yes, we're going to open our doors to you. and all of us have turned our backs on the implementation of that process. >> why had such a low number. even with the tremendous number of visas you have given out at the end of to 13, it's still not a big chunk of the total visas that congressional kated. was's the holdup? >> well, this is a complicated program to set up. for one thing it means setting up actually having immigrant visas issued it in afghanistan which we didn't do at all until 2011. and it's also a complicated set of factors that we have to balance in each of the individual applicant's cases. and so the important thing is that we've been learning our lessons over time. we've been remi

. >> bloomberg contributing editor david kirk patrick and mike cory johnson.wo of silicon valley's top vcs are leaving to start their own funds. two women are stepping out on their own. ♪ >> this is the best of bloomberg west, i am emily chang. in a field dominated by men, two female venture capitalists are stepping up to start their own firm. cory johnson and i sat down with both of them to talk about why they launched the new firm. >> i think both jennifer and i felt like this is our entrepreneurial thing. it is like when you see a vision and you share it. we thought this is a great time in the market to be focused on seed and early-stage investing around mobility as a theme. to work with somebody that you have known for over two decades. >> was this a difficult decision for you, jennifer? >> no, i have been in the business for 17 years and it is a great opportunity and time. frankly, if not now, then when? we have been fortunate on our careers as apprentices and now we are at the top of our game in our respective firms and we thought this is an opportunity

kirk. >> mr. chairman, i just wanted to highlight and praise dr. collins for the a.m.p. effort that brings together ten pharmaceutical companies. one headquartered in illinois. biogen. smith kline, johnson & johnson. institutionally these are all shareholder sponsored entities who all are going to be very interested in bringing something to market eventually which actually means actual patients will be helped. and not 25 year -- with all these institutions coming in to play they are only interested in the clinical application of what they find. and for a lot of the people, i'm sure that's where they are most focused on. >> senator, i appreciate your raising a.m.p. because i'm personally very excited about this and put close to three years in trying to build the momentum and was thrilled that it was possible to announce this just a couple of weeks ago. it is unprecedented to have nih and academic researchers getting together around the same table with equal financial contribution, with these ten pharmaceutical companies to say this is a hard problem let's work on it together. and with agreement that all the data is going to be publicly accessible. so we're calling this no longer a compet